Recent Update:
Agents that target disease pathways
Antibodies (monoclonal) such as Rituxan
Antibiotic therapies for some types of lymphoma
Balancing therapy-related risks and benefits
Best practice - NCCN guidelines
Biologics Interferon, Neupogen, Leukine ...
Tips on subcutaneous injections
Biomarkers
Bone marrow (stem cell) transplants TIPS
Allogeneic: Mini / Autologous / Cord blood
Auto versus Allo SCT |
Donor Lymphocyte Infusions (DLI)
HLA-typing and Background Harvesting / Mobilizing stem cells
Graft vs Host Disease | Patient stories Resources
Chimeric Antigen Receptor T-cells (CAR T-cells)
Chemotherapy
Alphabetical index of agents
Agents grouped by mechanism
CHOP chemotherapy
Common chemo protocols (APO...VBM)
Comments on chemo - importance in lymphoma
Liposomal (encapsulated) types Low dose (metronomic) chemotherapy PEP-C Outcome abstracts - Frontline Treatment support for chemotherapy
Clinical Trials
Focus on Clinical Trials
Find by Type of Lymphoma & Treatment Status
What's New - Trials of Interest By Type of Agent
New Trials
Complementary and Alternative Medicine
Elderly patients - treatment protocols and resources
Evaluating medical claims recognizing bias; limits of abstracts, what makes information credible.
Graft vs Host Disease
Informed consent
Immune-based therapies
Programming T-cells
Immune Checkpoint Blockade
MDS (Myelodysplastic Syndrome)
Nanotechnology
Ofatumumab for CLL / follicular lymphoma
Off-label use of treatments for lymphoma
Photopheresis
Pipeline new agents with links to clinical trials
Pregnancy During Lymphoma Treatment
Progress Review Group (PRG) research objectives
Quality of life (patient reported outcomes)
PAL: Providing support and evidence-based information, independent of health industry funding
|
Radio-immunotherapy
Zevalin ... and centers
2016, June: Rationale for continued study of Radioimmunotherapy
RIT for bulky disease?
Radiofrequency Ablation (RFA)?
Radiotherapy
Side effects | Treatment support for
Refractory lymphomas
protocols for lymphomas resistant to standard therapies
Protocols | Clinical Trials
Remissions & Response background & terms
Also Spontaneous regressions
Risks and benefits - balancing | Treatment-related Risks
Rituxan - Basics ... Side effects ...
Check list what to expect, bring, do.
Abstracts | Maintenance news and views
Side effects common to treatments
Splenectomy
Stem cell Transplant
Surgery for Lymphoma? (a common question)
T-cell therapies for lymphoma
CARs - Engineered T-cells - Find trials
Treatments & Decisions
Goals | Types | Outcomes | Interventions
PROTOCOL TYPES:
Standard Off-label ... etc.
BEST PRACTICE GUIDELINES
(Standard of Care):
NCCN.org PDF (login req.)
NCI Cancer.gov
Treatment decisions - factors that can influence treatment goal, type, and timing and
Considerations at relapse
Experts on treatment
Treatment outcome abstracts
Treatment Support
Treatment Timing?
Time to Progression comparing protocols for first line treatment of indolent NHL | Frontline
Treatment settings frontline, relapse, survival
Watchful Waiting
Transformation background and treatment
Vaccines investigational patient-specific therapeutic vaccines
Categorized abstracts | Outcome Data
What's a Drug?
|